Griffonia: benefits, dosage, contraindications

Mis à jour le

Griffonia is a medicinal plant native to West Africa (Ghana, Togo, Senegal...), belonging to the Fabaceae family (legumes). Widely used in traditional medicine, Griffonia grows naturally in forests as a vine or in savannas as a straggling shrub whose trunk can reach 7 cm in diameter. Griffonia contains a high level of 5-HTP, the active precursor of serotonin. The seeds can contain up to 10% 5-HTP. People suffering from anxiety, depression, insomnia, and other mood disorders often have low serotonin levels. Serotonin is a neurotransmitter that plays a crucial role in regulating mood and well-being. Tryptophan is also responsible for the synthesis of melatonin, the true "sleep hormone", as it plays an essential role in the sleep-wake cycle. This plant therefore has anxiolytic properties and contributes to the regulation of mood and sleep.

Scientific name(s)

Griffonia simplicifolia

Family or group: 

Plants

Active ingredients:

5-HTP

Alkaloids

Griffonine

Lectins


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Depression
✪✪✪✪✪

Clinical studies have shown that oral intake of 5-HTP for 2 to 3 weeks improves depressive symptoms in some patients. Because of its ability to increase serotonin levels, L-tryptophan helps combat depressive symptoms. Indeed, studies show that low tryptophan levels in healthy subjects lead to deficits similar to those observed clinically in cases of depression. As early as 1976, J. Walinder et al. demonstrated the potentiation of the action of a psychotropic drug used as an antidepressant, clomipramine, by tryptophan. Consistently, a 28-day double-blind clinical trial in 1983 confirmed that 5-HTP, a precursor of serotonin, in combination with clomipramine (a tricyclic antidepressant), has definite therapeutic potential in the treatment of depression. In this study, it was observed that in depressed patients, the combination of this tricyclic antidepressant and 5-HTP significantly improved the Hamilton Depression Rating Scale score compared with a clomipramine-and-placebo combination. Overall, it was found that in subjects suffering from mild to moderate depression, tryptophan supplementation proved effective and without side effects. Thus, by promoting serotonin synthesis, tryptophan significantly improves symptoms of anxiety and depression. Tryptophan also appears to be an effective treatment for seasonal depression. On the other hand, the comparison of the effectiveness of a serotonin reuptake inhibitor (fluvoxamine (Luvox)) with that of 5-HTP revealed equivalence between the two treatments after two weeks of treatment in depressed patients. However, despite the beneficial effects demonstrated by clinical research, the trials remain small and present methodological problems. Larger, higher-quality studies on larger patient populations are necessary to confirm these results. It is interesting to note that, unlike selective serotonin reuptake inhibitors (SSRIs), which conserve serotonin, the active ingredient in Griffonia allows the body to produce it. Above all, Griffonia has been shown to have fewer side effects (dry mouth, loss of libido) and to allow better tolerance of the treatment. In the trials, the administered dose ranged from 150 to 800 mg of 5-HTP per day for 2 to 6 weeks.

Posologie

posologieOral administration: seed

posologie150 - 800 mg

duration6 weeks

populationAdults

formulationStandardized 5-HTP extract


Synergies

The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study
Clinical evaluation of 5-hydroxy-L-tryptophan as an antidepressant drug.
Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study
A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.
Management of depression with serotonin precursors
The effects of dietary tryptophan on affective disorders.
The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
Tryptophan and 5-hydroxytryptophan for depression
Nutritional supplements in depressive disorders
Efficacy of light versus tryptophan therapy in seasonal affective disorder
Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression
Potentiation of the antidepressant action of clomipramine by tryptophan
Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms
Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study.
A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant.
Kynurenine pathway in psychosis: evidence of increased tryptophan degradation
Natural products of relevance in the prevention and supportive treatment of depression

Weight control
✪✪✪✪✪

5-HTP reduces appetite and cravings: it is of interest for people who need to lose weight or who suffer from bulimia; this is directly related to its satiating properties. Under these conditions, a diet supplemented with tryptophan would not only help prevent neuropsychiatric symptoms but could also be of great use in treating uncontrolled weight gain. An Italian team studied the effect of a Griffonia extract on satiety in 20 overweight women. In this double-blind, placebo-controlled study, the extract was administered for 4 weeks together with a hypocaloric diet for both groups. The results show a significant decrease in the sensation of appetite (assessed by the Haber score), body mass index (BMI), and arm and waist circumferences in the treated group compared with placebo.

Posologie

posologieBy mouth: seed

posologie250 - 300 mg

duration4 weeks

populationWomen, Adults

formulationextract standardized to 5-HTP


Sleep disorders
✪✪✪✪✪

L-tryptophan, as a precursor of melatonin, naturally induces sleep. In fact, there is now substantial experimental evidence that L-tryptophan promotes rapid, calm sleep onset, as well as sleep duration and quality. As such, by having a favorable effect on melatonin secretion, L-tryptophan may help prevent mild insomnia. A 2013 scientific study reports that a cereal-based intake high in tryptophan may improve sleep efficiency. Also, L-tryptophan may be effective against sleep apnea syndromes. By reducing these periodic episodes of breathing cessation during the night, L-tryptophan could lead to improved sleep quality. In normal subjects, administration of 5-HTP significantly increases the duration of REM sleep. Similarly, in moderately insomniac patients, low doses of 5-HTP significantly improve the duration and depth of sleep.

Posologie

posologieBy mouth: seed

posologie240 - 900 mg

populationAdults

formulationstandardized extract in 5-HTP


Synergies


Migraine
✪✪✪✪✪

In migraine patients, taking 5-HTP for 6 months shows efficacy equivalent to a reference antimigraine drug (methysergide). nn5-HTP also has efficacy comparable to a beta-blocker and significantly reduces the frequency of migraine attacks and the use of analgesics.nnA dose of 600 mg of 5-HTP per day in divided doses was used. nn

Posologie

posologieOral: seed

posologie600 - 600 mg

duration6 - months

populationAdults

formulationstandardized extract in 5-HTP


Synergies


Fibromyalgia
✪✪✪✪✪

In patients with fibromyalgia, reduced levels of serotonin metabolites in the cerebrospinal fluid have been reported, suggesting the involvement of a serotonin deficit in the pathogenesis of the disease.nnIn a study of fibromyalgia patients, administration of 5-HTP for 30 days reduced the number of painful tender points and their intensity, as well as morning muscle stiffness and anxiety compared with placebo.nnAnother study reports that combining 5-HTP with a monoamine oxidase inhibitor (MAOI) is the most effective treatment for fibromyalgia-related pain compared to a serotonin-norepinephrine reuptake inhibitor (amitriptyline) or to an MAOI alone.nnThe dose used was 100 mg of 5-HTP three times a day for 30 to 90 days.nn

Posologie

posologieOral: seed

posologie300 - 100 mg

duration90 - days

populationAdults

formulationstandardized extract in 5-HTP


Properties


Antidepressant

full-leaffull-leaffull-leafempty-leaf

The seeds of Griffonia contain a high concentration (5-10%) of 5-HTP, an amino acid precursor of serotonin. This neurotransmitter, which influences mood, is used to treat mental disorders (depression, anxiety) and stress. Most studies have been conducted on the activity of 5-HTP, the main constituent of Griffonia simplicifolia. 5-HTP crosses the blood-brain barrier and is converted into serotonin. Consequently, it increases serotonin levels in the CNS (central nervous system) in the same way as classical antidepressants acting on the serotonergic system. Although the exact etiology of depression is not known, it is widely accepted that impaired serotonergic activity plays a significant role in its pathophysiology. Indeed, recent data have more directly shown the involvement of serotonin in depression. On one hand, serotonergic dysfunction has been repeatedly demonstrated by biochemical assays in depressed subjects; on the other hand, the data seem to emphasize that such dysfunction may be linked to genetic predispositions. Finally, the most recent studies using advanced imaging techniques have shown a decrease in the binding capacity of a type of serotonergic receptor.

Usages associés

Depression

Sedative

full-leaffull-leafempty-leafempty-leaf

L-tryptophan, as a precursor of melatonin, naturally induces sleep. In this regard, several studies have highlighted the sedative and hypnotic effects of 5-HTP, the hydroxylated metabolite of tryptophan.

Usages associés

Sleep disorders

Analgesic

full-leafempty-leafempty-leafempty-leaf

Increases in beta-endorphin levels in the CNS (central nervous system) have been reported after administration of 5-HTP, suggesting that it may have analgesic effects.

Usages associés

Migraine, Fibromyalgia

Satiating

full-leafempty-leafempty-leafempty-leaf

It is believed that serotonin, whose levels are increased by 5-HTP, plays a role in regulating food intake in the hypothalamus. Indeed, it helps reduce feelings of hunger and calorie intake.

Usages associés

Weight control

Anxiolytic

full-leafempty-leafempty-leafempty-leaf

Griffonia seed extracts, rich in 5-HTP, naturally stimulate mood through the production of serotonin. Serotonin then promotes feelings of well-being, relaxation, confidence, and calm to counter anxiety disorders. Overall, it has been observed that in subjects suffering from mild to moderate depression, tryptophan supplementation proved effective and without side effects. Thus, by promoting serotonin synthesis, tryptophan significantly improves anxiety symptoms. Tryptophan, metabolized into 5-HTP, has been used by elite athletes for many years because it is known to help improve training outcomes and also significantly reduce performance-related anxiety.

Usages associés

Depression


Safe dosage

Adults 18 years and older: 275 mg - 500 mg (standardized extract)

5-HTP is safe when taken orally at appropriate doses. No toxicity has been reported with doses equal to or less than 50 mg/kg body weight. However, doses of 100 to 200 mg/kg body weight have been associated with serotonin syndrome in animals when administered alone.


Interactions

Médicaments

Antidepressant: strong interaction

The concomitant use of serotonergic antidepressants and 5-HTP could increase the risk of serotonergic side effects, including serotonin syndrome and cerebral vasoconstrictive disorders. These drugs include selective serotonin reuptake inhibitors (SSRIs) and tricyclic and atypical antidepressants.

Monoamine oxidase inhibitor (MAOI): strong interaction

The combination of serotonergic drugs such as a non-selective monoamine oxidase inhibitor (MAOI) and 5-HTP could increase the risk of serotonergic side effects, including serotonin syndrome and cerebral vasoconstrictive disorders.

Carbidopa: moderate interaction

Carbidopa is sometimes used with 5-HTP to minimize peripheral metabolism of 5-HTP and increase the amount reaching the brain. However, this combination can also increase the risk of side effects, including hypomania, agitation, pressured speech, anxiety, insomnia, and aggression. The combination of carbidopa and 5-HTP may also increase the risk of scleroderma-like skin changes due to elevated serotonin levels.

Opioids: moderate interaction

The combination of serotonergic medications such as opioids and 5-HTP could increase the risk of serotonergic adverse effects, including serotonin syndrome and cerebral vasoconstrictive disorders. Examples of such medications include: meperidine, pentazocine, tramadol.

Sedatives: moderate interaction

Theoretically, the concomitant use of 5-HTP with medications that cause sedation could have additive effects.

Methysergide: moderate interaction

Because of the presence of 5-HTP, interactions are possible with any medication that modulates serotonin levels.

Plantes ou autres actifs

Sedative: minor interaction

Theoretically, the concomitant use of 5-HTP with herbs and supplements that have sedative properties could increase the risk of additive sedation. Some of these supplements include calamus, California poppy, catnip, hops, Jamaican dogwood, kava, St. John's wort, skullcap, valerian, yerba mansa, and others.


Precautions

Pregnant women: avoid

Avoid the use of 5-HTP in pregnant and breastfeeding women due to a lack of long-term toxicological data.

Breastfeeding women: avoid

Avoid the use of 5-HTP in pregnant and breastfeeding women due to a lack of long-term toxicological data.

Trisomy: avoid

In children with trisomy: cases of convulsions have been reported during prolonged treatment with 5-HTP.


Contraindications

Carcinoid tumor: contraindicated

Griffonia is contraindicated in cases of carcinoid tumors of the small intestine (tumors that develop from the endocrine cells of the small intestinal mucosa). It is also contraindicated in women with a personal or family history of hormone-dependent cancers (breast, uterus, ovary).